Related Experiment Video
Updated: Oct 14, 2025

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
1.9K
CARASIL - A Review of Patients from India
Dinesh Khandelwal1, Vaibhav Mathur1, Arvind Vyas1
1Department of Neurology, SMS Medical College, Jaipur, Rajasthan, India.
Neurology India
|November 8, 2021
Summary
Cerebral small vessel disease (CSVD) is a significant cause of vascular dementia. This review highlights Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL) in India, emphasizing genetic testing for HTRA1 mutations.
Area of Science:
- Neurology
- Genetics
- Vascular Diseases
Background:
- Cerebral small vessel disease (CSVD) frequently causes vascular dementia.
- While often sporadic, familial monogenic causes are increasingly recognized.
- Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL) is a rare autosomal recessive CSVD linked to HTRA1 gene mutations.
Purpose of the Study:
- To review the Indian landscape of CARASIL.
- To highlight the importance of HTRA1 genetic mutation testing.
- To present a new case from North India.
Main Methods:
- Literature review of CARASIL in India.
- Analysis of previously reported cases.
- Presentation of a new patient case with clinical, imaging, and genetic data.
Main Results:
- Indian literature on CARASIL is limited, with few reported familial cases confirmed by mutation analysis.
- HTRA1 genetic mutation testing is becoming more accessible in India.
- A new case from North India with confirmed HTRA1 mutation is presented.
Conclusions:
- Increased availability of HTRA1 genetic testing in India should be encouraged for diagnosing CARASIL.
- Genetic testing aids in accurate diagnosis, prognosis, and avoids unnecessary investigations and treatments.
- This review underscores the need for greater awareness and diagnostic capabilities for CARASIL in India.
Related Concept Videos
Clinical Trials: Overview
3.8K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.8K
Bioavailability Study Design: Healthy Subjects Versus Patients
19
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
19
Pharmacovigilance
1.1K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.1K
Clinical Trials
9.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
9.7K

